Literature DB >> 7282721

Acute renal failure associated with chronic antacid ingestion.

C H Millette, G L Snodgrass.   

Abstract

A case of acute renal failure apparently caused by ingestion of large amounts of a magnesium-containing antacid is reported. A 51-year-old man was hospitalized with complete anuria and an associated hyperkalemia and hypermagnesemia. He had been taking 25-30 magnesium trisilicate-aluminum hydroxide (Gelusil) tablets daily for several years to relieve symptoms of gastritis. A renal sonogram and a retrograde pyelogram demonstrated the presence of multiple renal stones that were found to be composed of magnesium-ammonium-phosphate crystals. The patients required surgical removal of the stones and placement of ureteral catheters before renal function improved. An intravenous pyelogram performed four weeks after discharge revealed no apparent residual damage. The etiology, incidence, and characteristics of magnesium-ammonium-phosphate stones are discussed. Previous reports of renal stones associated with magnesium-containing antacids are reviewed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7282721

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  4 in total

1.  Pharmacokinetics and gamma scintigraphy evaluation of two enteric coated formulations of didanosine in healthy volunteers.

Authors:  Bharat Damle; Ismat Ullah; Walter Doll; Gary Wiley; Catherine Knupp
Journal:  Br J Clin Pharmacol       Date:  2002-09       Impact factor: 4.335

2.  [Silica-containing urinary stones--clinical issues to keep in mind].

Authors:  M May; C Helke; K Kubenz; M Seehafer; M Wolter; B Hoschke
Journal:  Urologe A       Date:  2005-01       Impact factor: 0.639

Review 3.  Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.

Authors:  Michel Daudon; Vincent Frochot; Dominique Bazin; Paul Jungers
Journal:  Drugs       Date:  2018-02       Impact factor: 9.546

Review 4.  Drug-induced renal calculi: epidemiology, prevention and management.

Authors:  Michel Daudon; Paul Jungers
Journal:  Drugs       Date:  2004       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.